US Corporate Distress Financial Stress SEC Filings — April 29, 2026

29-04-2026

Kopin Corporation announced a strategic collaboration with Fabric.AI to develop Neural I/o™ MicroLED-based optical interconnect technology for AI infrastructure, securing a $15M initial development order to fund the demonstration chipset. Under the agreement, Kopin owns 19.9% of Fabric.AI and will serve as the exclusive manufacturer of the Neural I/o™ chipsets. This partnership leverages Kopin's MicroLED expertise to address power and bandwidth challenges in AI data centers, positioning the company as a key player in the expanding AI hardware ecosystem.

• ·Announcement date: April 28, 2026
• ·Filing date: April 29, 2026
• ·Kopin has over 40 years of experience in advanced display technologies

29-04-2026

Atkore Inc. entered into settlement agreements on April 28, 2026, agreeing to pay $72.5 million to Direct Purchaser Plaintiffs and $64 million to Non-Converter Seller Purchaser Plaintiffs (totaling $136.5 million) in the In re PVC Pipe Antitrust Litigation, to be recorded as a non-operating expense in the quarter ended March 27, 2026. The company expects no material adverse effect on liquidity or leverage metrics and believes the settlements reduce legal uncertainty without admitting fault. However, End User Plaintiffs' claims remain pending, and court approval is required with no assurance of finalization.

• ·Settlement payments to be made on or about 21 days after preliminary court approval.
• ·Execution does not constitute admission of fault or liability.
• ·Company plans to vigorously defend if settlements not approved.
• ·Litigation centralized in U.S. District Court for the Northern District of Illinois.

29-04-2026

OppFi Inc. announced a definitive agreement to acquire BNCCORP, Inc. and BNC National Bank in a cash and stock transaction valued at approximately $130 million, expected to close in Q4 2026, combining OppFi's digital lending platform with BNC's national bank charter for geographic expansion, product diversification, and synergies of at least $60 million in year 1 post-closing. The deal is projected to be significantly accretive with adjusted EPS growth of more than 25% in 2027 and more than 40% in 2028, alongside adjusted ROA of 10%+ and ROE of 35%+ by 2028. OppFi also simplified its corporate structure by collapsing its Up-C into a traditional C-Corp, terminating the TRA with a $40.8 million payment but recording $466 million in tax amortizable goodwill expected to yield $111 million in future cash tax savings.

• ·BNC headquartered in Glendale, AZ, with deposit cost of less than 2%.
• ·Transaction approved by both boards; subject to BNCC stockholder approval, OCC, Federal Reserve, FDIC approvals.
• ·OppFi to become bank holding company; contribute assets to OppFi Bank, N.A.; BNC as community banking division led by Dan Collins.
• ·OppFi holds 35% equity in Bitty Holdings, LLC.

29-04-2026

Two Harbors Investment Corp (TWO) and CrossCountry Mortgage, LLC (CCM) announced an amended merger agreement, increasing the per-share cash consideration for TWO common stock to $11.30 from $10.80 under the original terms, following a review of an unsolicited competing proposal from UWM Holdings Corporation on April 20, 2026. TWO's Board unanimously approved the amendment, recommending stockholders vote in favor at the special meeting on May 19, 2026, with closing expected in Q3 2026; Series A, B, and C Preferred Stock will be redeemed at $25.00 per share plus dividends. The deal provides fixed all-cash consideration without financing conditions, deemed superior for certainty.

• ·Original merger agreement dated March 27, 2026.
• ·TWO headquartered in St. Louis Park, MN.
• ·CCM operates in all 50 states, D.C., and Puerto Rico; NMLS #3029.
• ·Advisors: Houlihan Lokey (financial) and Jones Day (legal) for TWO; Citi (exclusive financial) and Simpson Thacher & Bartlett LLP (legal) for CCM.
• ·TWO to file proxy supplement; prior votes remain valid but changeable.
• ·TWO intends regular quarterly dividends pre-closing.
• ·Post-closing: TWO delisted from NYSE, becomes wholly owned subsidiary of CrossCountry.

29-04-2026

Vulcan Materials reported first quarter 2026 total revenues of $1,756 million, up 7% YoY from $1,635 million, with gross profit increasing 16% to $423 million and adjusted EBITDA rising 9% to $447 million at a 25.5% margin (up 40 bps). Aggregates segment shipments grew 5% to 50.0 million tons with freight-adjusted sales price up 4% to $22.80 per ton, driving gross profit per ton up 7% to $8.01; however, non-aggregates concrete gross profit margin was a low 5% and asphalt shipments grew only 2%, while SAG expenses declined 2% but prior-year shipments were weather-impacted. The company reaffirmed full-year adjusted EBITDA outlook of $2.4-2.6 billion, reported strong liquidity with debt-to-EBITDA at 1.9x, and returned $217 million to shareholders.

• ·Houston asphalt and construction business divested in Q4 2025.
• ·California ready-mixed concrete business disposition expected to close in Q2 2026.
• ·Total debt to TTM Adjusted EBITDA ratio of 1.9x as of March 31, 2026.
• ·TTM return on average invested capital of 16.0%.
• ·Conference call scheduled for April 29, 2026 at 9:00 a.m. CT.

29-04-2026

Chiesi Group has entered a definitive agreement to acquire KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) for $27.00 per share in cash, implying a total equity value of approximately $1.9bn, representing a 36% premium to KalVista's 30-day volume-weighted average share price as of April 28, 2026. The acquisition adds EKTERLY® (sebetralstat), the first oral on-demand therapy for hereditary angioedema (HAE), which generated $49M in US sales in 2025 following its July 2025 launch, to Chiesi's rare disease portfolio. The transaction, unanimously approved by both boards, is expected to close in Q3 2026 subject to customary conditions including regulatory approvals and tender of a majority of shares.

• ·EKTERLY® (sebetralstat) approved in US, UK, EU, Japan, Switzerland, Australia, Singapore for HAE attacks in patients 12+ years old
• ·US regulatory filing planned for 2026 to expand sebetralstat to children aged 2-11
• ·Transaction not subject to financing condition; involves tender offer followed by second-step merger
• ·Chiesi 2030 strategic revenue target of €6bn

29-04-2026

Sangamo Therapeutics, Inc. (SGMO) received a Nasdaq delisting notice on April 28, 2026, for failing to meet the minimum bid price requirement of $1.00 per share after compliance periods ending October 27, 2025, and April 27, 2026. Trading on Nasdaq Capital Market will suspend at the open on May 5, 2026, despite plans to appeal to a Nasdaq Hearings Panel, which stays delisting but not suspension. The company has approval to trade on OTCQB Venture Market starting May 5, 2026, under the symbol SGMO.

• ·Previous notices received on April 30, 2025, and October 29, 2025.
• ·Compliance periods: until October 27, 2025 (initial), extended to April 27, 2026.
• ·Nasdaq Listing Rules referenced: 5550(a)(2), 5800 Series, 5815(a)(1)(B)(ii)(d).
• ·Annual Report on Form 10-K filed with SEC on March 30, 2026.

29-04-2026

Allbirds, Inc. entered into a Class A Common Stock Sales Agreement with Chardan Capital Markets LLC on April 28, 2026, allowing the company to issue and sell shares of its Class A Common Stock (par value $0.0001 per share) on an at-the-market basis through Chardan as exclusive agent, pursuant to an existing Form S-3 Registration Statement (No. 333-288434). Sales are to be initiated via Placement Notices specifying parameters such as number of shares, sales period, daily limits, and minimum price, with Chardan earning compensation per Schedule 3 (details omitted). No maximum number of shares or committed proceeds are specified, and sales are subject to conditions including suspension during material non-public information periods or earnings announcements.

• ·Agreement effective via Placement Notices; Chardan has no obligation unless notice accepted.
• ·Sales prohibited during possession of material non-public information or earnings blackout periods.
• ·Settlement occurs on the first Trading Day following sales, with Net Proceeds to Company after Chardan's commission.

29-04-2026

Visteon Corporation executed Amendment No. 8 to its Credit Agreement on April 27, 2026, introducing new Revolving Credit Commitments of $400,000,000 to refinance existing revolving credit loans and commitments, and new Term Loans of $300,000,000 to repay outstanding Original Term Loans in full. The amendment also transfers the Administrative Agent role from Citibank, N.A. to Bank of America, N.A., with BofA Securities, Inc., JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, and Wells Fargo Securities, LLC acting as joint lead arrangers. No changes in overall debt levels are indicated, maintaining the company's leverage profile.

• ·Amendment dated April 27, 2026; original Credit Agreement dated April 9, 2014
• ·All Original Revolving Credit Commitments terminated on Amendment No. 8 Effective Date
• ·Original Term Loans repaid in full with interest, fees, and other amounts using proceeds from New Term Loans

29-04-2026

Hestia Insight Inc.'s Board unanimously approved the Strategic Divestiture and Settlement Agreement, transferring 100% interest in subsidiary Hestia Investments Inc. to Chairman and President Edward Lee to settle a $500,000 compensation liability for six years of unpaid service, thereby preserving company cash. The company retains 20% participation in the subsidiary's net earnings for two years benefiting stockholders of record as of April 30, 2026. While this avoids cash outflow, it relinquishes full ownership and control of the subsidiary.

• ·Unanimous written consent dated April 15, 2026
• ·Filing date: April 29, 2026
• ·Benefits stockholders of record as of April 30, 2026

29-04-2026

GD Culture Group Limited announced that its AI interactive novel app, Fato: Interactive Novel, is now publicly available for free download on the Apple App Store for iPhone and iPad users worldwide, marking a key milestone in its AI immersive reading platform initiative launched in August 2025. The app features choice-driven branching narratives, immersive chat-like interactions, and personalized story worlds in a dark mystery format. CEO Xiaojian Wang described the launch as a defining moment for the company's transition into interactive narrative entertainment.

• ·Platform concept announced and global creators invited in August 2025
• ·App download link: https://apps.apple.com/ca/app/fato-interactive-novel/id6761399590
• ·References SEC filings: 10-K on March 27, 2026; 10-Q on April 10, 2026

29-04-2026

Hawthorn Bancshares, Inc. (HWBK) announced the acquisition of FSC Bancshares, Inc. in a cash and stock transaction valued at approximately $28.3 million, based on HWBK's closing stock price of $34.57 on April 28, 2026. The transaction is expected to be accretive to earnings per share by 20% on a fully phased-in basis and add approximately $384 million in assets and 9 branches, strengthening presence in northern Missouri; however, it will result in 9.8% tangible book value dilution at closing, to be earned back in approximately 3.0 years. Completion is targeted for Q3 2026, subject to shareholder and regulatory approvals.

• ·Data based on financials as of March 31, 2026.
• ·Raymond James & Associates, Inc. (financial advisor to Hawthorn); Hunton Andrews Kurth LLP (legal counsel to Hawthorn).
• ·Northland Capital Markets (financial advisor to FSC); Stinson LLP (legal counsel to FSC); Olsen Palmer LLC (fairness opinion to FSC).
• ·Transaction unanimously approved by boards of both companies; expected to qualify as tax-free reorganization.

29-04-2026

Lord Abbett PCF Financing 2 LLC, borrower and affiliate of Lord Abbett Private Credit Fund, entered into Amendment No. 1 to its Loan and Security Agreement dated December 1, 2025, increasing Royal Bank of Canada's lender commitment from $300,000,000 to $400,000,000 and the Target Transaction Par Amount from $430,000,000 to $575,000,000, effective April 23, 2026. The amendment confirms no Defaults or Events of Default are occurring and that all representations and warranties remain true. Conditions precedent including legal opinions, consents, fees, and good standing certificates were satisfied.

• ·Amendment ratified original Loan Agreement except as expressly modified.
• ·Governed by New York law.
• ·Requires execution by all parties, legal opinions from Dechert LLP, fees, and good standing certificates as conditions precedent.

29-04-2026

Aterian, Inc. signed a definitive agreement to sell its marquee e-commerce brand portfolio—including Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct—to Trademark Global, LLC for a base cash purchase price of $18 million, subject to net working capital and other adjustments, with net proceeds expected to be distributed to stockholders in Q3 2026 potentially via a Contingent Value Right (CVR). Concurrently, the company announced a $7 million strategic investment through a private placement of convertible preferred stock with David Lazar ($3.5 million per tranche), who joined the board and will become CEO after the second tranche closes, succeeding Arturo Rodriguez. Post-sale, Aterian will operate smaller remaining legacy brands Vremi and Xtava.

• ·Proxy statement seeking stockholder approval for both transactions expected in early May 2026.
• ·Transactions expected to close in Q2 2026; net proceeds distribution (including CVR for tariffs refunds and other liquidations) in Q3 2026.
• ·Trademark Global expected to onboard majority of Aterian employees dedicated to sold brands.
• ·David Lazar and affiliates waived rights to Asset Sale proceeds and CVR.

29-04-2026

On April 29, 2026, International Battery Metals Ltd. issued 34,315,465 Units at USD $0.08 each to EV Metals 9 LLC, an affiliate controlled by director Jacob Warnock, raising gross proceeds of USD $2.8 million as the fourth follow-on under the March 2025 LOI with EV Metals 7 LLC. Each Unit consists of one common share and one warrant exercisable at C$0.148 for four years. The Company paid a 5% structuring fee on gross proceeds to Jacob Warnock in cash.

• ·Units subject to four-month plus one-day hold period under Canadian securities laws and restricted under U.S. Securities Act.
• ·Sale relied on exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
• ·Warrants exercisable at C$0.148 per share for four years from issuance.

29-04-2026

CalEthos, Inc. secured a $15 million loan from SFO IDF LLC, an entity controlled by a trust for family members of director Sean Fontenot, issuing a promissory note at 8% interest maturing December 31, 2028, and a 7-year warrant for 6 million shares at $0.50 per share after refinancing $1 million in prior notes to increase the principal to $16 million. Proceeds will fund a proposed joint venture for data center development, including a $6 million certificate of deposit for a gas purchase agreement. However, the letter agreement requires preferential payments to SFO IDF of up to $37.5 million from Phase 1 proceeds (company's expected 50% share of $75 million) or makeup from net income, plus $10 million per 300MW in later phases, posing future cash flow and dilution risks.

• ·Promissory note issued April 23, 2026, matures December 31, 2028.
• ·Warrant is for seven years with exercise price of $0.50 per share.
• ·Prior notes bore 10% interest and were to mature December 31, 2026.
• ·Warrant issued under Section 4(a)(2) and/or Rule 506 of Regulation D exemption.

29-04-2026

INVO Fertility, Inc. received a Nasdaq letter on April 23, 2026, notifying failure to timely file its Form 10-K for the year ended December 31, 2025, violating Listing Rule 5250(c)(1). The company's common stock continues to trade on the Nasdaq Capital Market under symbol IVF with no immediate delisting effect. The company has 60 days to submit a compliance plan, potentially granting up to 180 days or until October 13, 2026, to file and expects to do so soon.

• ·Securities: Common Stock, $0.0001 par value, trading symbol IVF.
• ·Press release issued April 29, 2026, attached as Exhibit 99.1.

29-04-2026

Danaher Corporation issued €3 billion in senior notes on April 29, 2026, consisting of €500 million Floating Rate Notes due 2028, €750 million 3.250% Notes due 2030, €750 million 3.625% Notes due 2034, and €1 billion 4.000% Notes due 2038, with net proceeds of approximately €2.98 billion. The proceeds are intended primarily to fund the proposed acquisition of Masimo Corporation, with possible use for general corporate purposes. The notes include special mandatory redemption at 101% if the Masimo Acquisition is not consummated by November 16, 2026, or earlier termination.

• ·Interest on Floating Rate Notes paid quarterly starting July 29, 2026; fixed rate notes paid annually starting April 29, 2027.
• ·Early redemption option prior to Par Call Dates at treasury plus 10-15 bps; at par thereafter.
• ·Notes issued under Base Indenture dated December 11, 2007, and Sixth Supplemental Indenture dated April 29, 2026.

29-04-2026

QuickLogic Corporation (NASDAQ: QUIK) entered into a new $10 million revolving credit facility with Sunflower Bank, effective April 27, 2026, replacing its prior agreement with Heritage Bank of Commerce and providing enhanced financial flexibility for three years until maturity on April 24, 2029. The facility supports general corporate purposes, including working capital and strategic initiatives such as Strategic Radiation Hardened FPGA development for the US Government, eFPGA Hard IP licensing expansion, and the Storefront business. No declines or flat performance metrics were reported.

• ·Facility is senior secured and part of an integrated banking solution.
• ·Additional details to be included in a forthcoming Form 8-K filing.

29-04-2026

Professional Diversity Network, Inc. entered into a Global Amendment with Streeterville Capital, LLC on April 28, 2026, reducing the Commitment Amount in the September 5, 2025 Securities Purchase Agreement from $20,000,000 to $8,000,000, which limits potential future funding. However, the amendment introduces a mechanism allowing the Company to reduce the Minimum Balance Amount by $0.70 for every $1.00 paid toward Pre-Paid Purchases, enabling releases of at least $50,000 from the Deposit Account upon request.

• ·Global Amendment filed as Exhibit 10.1
• ·Amends Transaction Documents as previously disclosed in 8-K on September 5, 2025

29-04-2026

Cleco Corporate Holdings LLC entered into a Term Loan Agreement dated April 24, 2026, with lenders including Regions Bank as Administrative Agent, providing for term loans in an aggregate principal amount of $250,000,000 (the Term Loan Facility). The facility supports general corporate purposes with no specific performance metrics, growth comparisons, or declines reported. Applicable margins are set at 1.500% for Term SOFR Loans and Daily Simple SOFR Loans, and 0.500% for Base Rate Loans.

• ·Agreement filed as Exhibit 10.1 in 8-K on April 29, 2026
• ·Effective Date conditions outlined in Section 4.01
• ·Lenders' Commitments detailed in Schedule 2.01

29-04-2026

On April 23, 2026, SmartKem, Inc. funded a bridge loan to Ferrox Critical Minerals in the principal amount of $2,300,000, evidenced by a convertible promissory note maturing October 30, 2026, with 5% per annum interest and a $200,000 origination fee received by SmartKem. The note provides conversion rights into Ferrox ordinary shares at the lower of fair market value or based on an $80,000,000 fully-diluted equity value, along with protective covenants, right of first refusal on fundamental transactions, and exclusivity through maturity. No performance declines or flat metrics are reported in this filing.

• ·Note includes customary negative covenants restricting Ferrox from redeeming equity, incurring or repaying indebtedness, paying dividends, disposing of assets, amending charter, or affiliate transactions.
• ·Right of first refusal granted to SmartKem on fundamental transactions including asset sales, mergers, recapitalizations, or equity/debt issuances constituting change of control.
• ·Exclusivity granted to SmartKem on any fundamental transactions through October 30, 2026.

29-04-2026

Lucid Group, Inc. adopted a Certificate of Designations authorizing 55,000 shares of Series C Convertible Preferred Stock, par value $0.0001 per share, with a 9% annual dividend rate payable quarterly starting June 30, 2026. The preferred stock is convertible into common stock subject to a Beneficial Ownership Limitation of 9.9% for most holders (infinity for PIF Investor) and other conditions including a Conversion Share Cap of 107.3265 common shares. No operational or financial performance metrics are provided in the filing.

• ·Dividend Payment Dates: March 31, June 30, September 30, December 31 commencing June 30, 2026.
• ·Beneficial Ownership Limitation: 9.9% of Common Stock for Other Investors; infinity for PIF Investor.
• ·Common Stock: Class A common stock, par value $0.0001 per share.

29-04-2026

Innovative Industrial Properties, Inc. (IIPR), as guarantor, supported its subsidiary IIP-IL 2 LLC in securing a $20,000,000 promissory note from Generations Bank dated April 24, 2026, filed via 8-K on April 29, 2026. The loan features a 9.00% fixed interest rate, interest-only payments until the 12-month conversion date, followed by 20-year amortization with a balloon payment at maturity on April 22, 2029, and includes a 1.50% origination fee plus tiered prepayment exit fees (3.0% year 1, 2.0% year 2, 1.0% up to 30 months). No prior period comparisons are available as this represents new financing.

• ·Loan Number: 820951505
• ·First Payment Date: May 25, 2026
• ·Conversion Date: 12 months following Effective Date (April 24, 2026)
• ·Maturity Date: April 22, 2029
• ·Prepayments prohibited before Conversion Date
• ·Late fee minimum $100, maximum $500 if payment >10 days late

29-04-2026

SunPower Inc. and its subsidiaries entered into a Pledge and Security Agreement dated April 23, 2026, with U.S. Bank Trust Company, National Association as Collateral Agent, to secure 10.0% Convertible Senior Secured Notes due 2029 issued under an Indenture of the same date. The agreement grants a security interest in substantially all personal property assets as Collateral, subject to specified Excluded Assets. No principal amount for the Notes or other financial performance metrics are disclosed in the filing.

• ·Excluded Assets include fee-owned Real Property, titled vehicles, certain leases/licenses, Excluded Capital Stock, intent-to-use Trademark applications (pre-Statement of Use), governmental licenses, and assets with material adverse tax consequences.
• ·Collateral excludes more than 65% of voting stock of Foreign Subsidiaries (unless a Guarantor).
• ·Agreement filed as Exhibit 10.1 to 8-K on April 29, 2026.

29-04-2026

Vestand Inc. received a Nasdaq staff deficiency notice on April 23, 2026, for failing to file its Form 10-K for the fiscal year ended December 31, 2025, and its previously delinquent Form 10-Q for the quarter ended September 30, 2025, due to an ongoing financial restatement, violating Nasdaq Listing Rule 5250(c)(1). The notice has no immediate effect on the listing of its Class A Common Stock (VSTD) on the Nasdaq Capital Market, but the company plans to submit an updated compliance plan to regain compliance by May 18, 2026, with no assurance of approval or success. A press release announcing the notice was issued on April 29, 2026.

• ·Previous Nasdaq deficiency notice issued December 2, 2025, for failure to file Form 10-Q (quarter ended September 30, 2025)
• ·Ongoing financial restatement disclosed in 8-K filed October 31, 2025
• ·Former name: Yoshiharu Global Co.
• ·Emerging growth company: Yes
• ·Address: 104 Apple Blossom Cir., Brea, CA 92821

29-04-2026

Anteris Technologies Global Corp., through its subsidiary Anteris Technologies Corporation, elected to discontinue additional development contributions to v2vmedtech, inc. under the April 18, 2023 Contribution and Stock Purchase Agreement after completing Stage 1 and during Stage 2, triggering a $400,000 break fee payment and termination of the related Development Agreement. v2v's initial shareholders may elect to acquire the Company's equity interest for aggregate contributions to date or reduce it to a capped minority ownership, with no decision yet communicated. The Company states this will not have a material adverse effect on its financial position or liquidity.

• ·Event occurred on April 28, 2026; filing dated April 29, 2026
• ·Discontinuation followed completion of Stage 1 during Stage 2 of the development program
• ·v2v has not yet informed the Company of its election regarding equity options

29-04-2026

BIO-Key International, Inc. filed a Certificate of Amendment to its Certificate of Incorporation, effecting a 1-for-10 reverse stock split of its common stock (par value $0.0001 per share), effective at 5:00 pm Eastern Time on April 29, 2026. Each ten shares outstanding immediately prior to the effective time will combine into one share, with fractional shares rounded up to the nearest whole share and no cash issued in lieu. The amendment was duly adopted pursuant to Section 242 of the Delaware General Corporation Law and signed by CEO Michael W. DePasquale on April 28, 2026.

• ·Old stock certificates will represent the adjusted number of post-split shares.
• ·No fractional shares issued; rounding up applied instead of cash payment.

29-04-2026

Churchill Capital Corp XII announced the pricing of its upsized $360 million initial public offering of 36,000,000 units priced at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-tenth of one redeemable warrant exercisable at $11.50 per share. The units will list on Nasdaq under the symbol 'CXIIU' commencing April 27, 2026, with separate trading of shares ('CXII') and warrants ('CXIIW') to follow. The offering, managed by Citigroup as sole book-running manager, is expected to close on April 29, 2026, subject to customary conditions, and includes a 45-day underwriter option to purchase up to 5,400,000 additional units for over-allotments.

• ·Company founded by Michael Klein for SPAC business combinations in any industry.
• ·Underwriting agreement grants 45-day over-allotment option.
• ·Registration statement declared effective by SEC; prospectus available via Citigroup or sec.gov.

29-04-2026

Everspin Technologies, Inc. entered into a $40,000,000 IDIQ Subcontract (Number S26-03-01) with Amentum Services Inc. on April 24, 2026, for RDT&E services on Toggle MRAM under a prime contract with NSWC Crane. The Firm Fixed Price agreement spans a 30-month base period from April 20, 2026, to November 21, 2028, with milestone payments across two phases to develop on-shore Toggle MRAM production capability for U.S. government strategic systems. No performance declines or risks beyond standard termination clauses are noted.

• ·Subcontract structured as IDIQ with Firm Fixed Price Task Orders
• ·Company provides process know-how and IP for Toggle MRAM manufacturing
• ·Contractor may terminate for convenience only if NSWC Crane terminates Prime Contract, reimbursing vendor costs
• ·Option periods exercisable unilaterally; possible 6-month extension at final option rates
• ·Full Agreement text to be filed as exhibit to Q2 2026 10-Q

29-04-2026

XMax Inc. (XWIN) entered into Securities Purchase Agreements on April 24, 2026, with six non-U.S. investors to sell 8,550,000 shares of common stock at $3.64 per share in a Regulation S private placement, for an aggregate offering price of $31,122,000. As of April 29, 2026, the company has 63,602,326 shares of common stock issued. No financial performance metrics or period-over-period comparisons were disclosed.

• ·Private placement exempt from registration under Regulation S.
• ·Form of Securities Purchase Agreements filed as Exhibit 10.1.

29-04-2026

Xos, Inc. entered into a Confidential Separation Agreement with former General Counsel and Secretary Christen T. Romero on April 24, 2026, clarifying terms of his separation effective January 10, 2025. The agreement includes a $110,000 cash lump sum payment, full acceleration and vesting of 120,000 restricted stock units subject to a 21-month incremental lock-up, potential additional $50,000 cash if liquidity targets or transactions are achieved within three years, and reimbursement of up to $9,500 in attorney's fees.

• ·Separation Agreement attached as Exhibit 10.1
• ·Romero resigned effective January 10, 2025
• ·RSU shares released subject to incremental lock-up over 21 months
• ·Potential additional payment contingent on Company achieving liquidity targets or transactions within three-year period following April 24, 2026

29-04-2026

Entegris, Inc. entered into Amendment No. 4 to its Credit and Guaranty Agreement dated November 6, 2018 (as previously amended), effective April 29, 2026, establishing new Revolving Commitments totaling $750 million to refinance and replace the existing Revolving Commitments. Morgan Stanley Senior Funding, Inc. acts as Administrative Agent and Collateral Agent, with Barclays Bank PLC, BofA Securities, Inc., Citibank, N.A., Goldman Sachs Bank USA, PNC Capital Markets LLC, Truist Securities, Inc., and Wells Fargo Securities, LLC appointed as joint lead arrangers and bookrunners. The amendment updates schedules, Swingline Lender commitments, Issuing Banks, and Pro Rata Shares, subject to standard conditions including solvency certification and repayment of prior obligations.

• ·Post-closing deliverables required within 90 days of Amendment No. 4 Effective Date.
• ·Existing Revolving Commitments automatically terminate on Amendment No. 4 Effective Date without further action.

29-04-2026

Polomar Health Services, Inc. received a notice on April 23, 2026, from ForHumanity, Inc. stating its intent to terminate and rescind the Product Fulfillment and Distribution Agreement (ForHumanity Agreement), which provided exclusivity for marketing certain pharmaceutical products in exchange for a $750,000 guaranteed payment ($500,000 paid to date) and revenue commitments including $1,750,000 for H1 2026 and $5,000,000 for full-year 2026. The Company disputes ForHumanity's claims of false representations, believes they lack standing and are in default, and is evaluating next steps. This development poses risks to exclusivity and future revenues from the agreement.

• ·Agreement initially executed March 12, 2025; amended March 17, 2025, September 23, 2025, December 5, 2025; Amended and Restated August 19, 2025.
• ·Initial term: 42 months, auto-renewal if revenue commitments met.
• ·Exclusivity granted through June 30, 2026; extendable to December 31, 2026 or June 30, 2027 based on revenue thresholds.
• ·IG4 provides account management services on behalf of the Company.
• ·Company solely responsible for fulfilling valid prescriptions.

29-04-2026

Auddia Inc. entered into a material definitive agreement via a Form of Exchange Agreement on April 23, 2026 (Item 1.01). The company conducted an unregistered sale of securities, relying on exemptions under Sections 3(a)(9) and 4(a)(2) of the Securities Act (Item 3.02). Exhibit 10.1 provides the details of the Exchange Agreement.

• ·Filing Date: April 29, 2026
• ·Event Date: 2026-04-23
• ·SEC Items: 1.01 (Entry into Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits)
• ·Exhibits: 10.1 (Form of Exchange Agreement), 104 (Cover Page Interactive Data File)

29-04-2026

On April 28, 2026, Nuveen Churchill Private Capital Income Fund entered into a Fee Waiver Agreement with Churchill PCIF Advisor LLC, waiving 50% of the incentive fee based on income for March 1-31, 2026. As of March 31, 2026, the Fund's aggregate NAV stood at $1.4 billion, investment portfolio fair value at $2.4 billion, and secured borrowings at $994.0 million, with modest 1-month returns of 0.01%-0.12% (flat performance) and YTD returns of 0.62%-0.87% across share classes. The Board declared regular net distributions of $0.153-$0.170 per share payable on or about May 28, 2026, supported by a weighted average portfolio yield of 8.75%.

• ·Portfolio composition: 92.90% first-lien debt, 2.62% second-lien, 2.10% mezzanine/structured, 2.38% equity at fair value.
• ·96.00% of debt investments at floating rate, 4.00% at fixed rate.
• ·Top industries: Services: Business (18.40%), Healthcare & Pharmaceuticals (14.23%), High Tech Industries (9.01%).
• ·PricewaterhouseCoopers LLP has not audited the presented financial data.

29-04-2026

American Rebel Holdings (NASDAQ: AREB, AREBW) announced the resumption of trading on Nasdaq at 11:00 a.m. ET on April 27, 2026, following a halt on March 20, 2026, after issuing 3,218,299 shares to CEDE & Co. to address the post-1-for-100 reverse split Publicly Held Shares deficiency (previously ~247,279 shares, below the 500,000 requirement). The company reports 4,132,655 shares issued and outstanding, with ~33,908 beneficial shareholders where 86% hold under 250 shares. However, it faces ongoing risks including the $1.00 minimum bid price requirement for 10 consecutive business days and a one-year Nasdaq Hearings Panel monitoring period for stockholders’ equity compliance.

• ·Reverse stock split (1-for-100) effective March 23, 2026.
• ·Split-adjusted prior reference price: $6.46.
• ·Nasdaq monitoring period for stockholders’ equity compliance confirmed November 21, 2025, lasting one year.
• ·Broadridge record date: April 14, 2026; last updated April 22, 2026.

29-04-2026

RYVYL Inc. received a Nasdaq notice on April 23, 2026, stating non-compliance with the $2.5M minimum stockholders’ equity requirement under Rule 5550(b)(1), with potential delisting of its Common Stock (RVYL) effective May 4, 2026, absent an appeal by April 30, 2026. The company filed its appeal on April 29, 2026, staying suspension pending a hearing. However, it expects stockholder-approved merger with RTB Digital, Inc. (April 1, 2026) to add over $20M in equity upon Nasdaq approval and closure, restoring full compliance.

• ·Stockholders approved merger at special meeting on April 1, 2026
• ·Appeal request filed with Nasdaq Hearings Panel on April 29, 2026
• ·Merger is final condition pending Nasdaq continued listing approval
• ·Common Stock: par value $0.001 per share, trading symbol RVYL on Nasdaq Capital Market

29-04-2026

Profusa, Inc. (formerly NorthView Acquisition Corp.) entered into a Note Modification and Conversion Agreement dated April 24, 2026, with NorthView Sponsor I LLC, amending a promissory note with an outstanding principal of $1,869,796, which is now non-interest bearing and matures on December 31, 2026. The Holder may optionally convert all or part of the principal into common stock at the greater of 95% of the closing price or a $0.35 floor price per share, but only after SEC registration effectiveness, subject to a 4.99% beneficial ownership limit (expandable to 9.99%). No prior conversion occurred under a rescinded April 6, 2026 agreement, leaving the full principal outstanding.

• ·Conversion requires delivery of Conversion Notice specifying amount and date no earlier than Registration Effective Date.
• ·Company must issue Conversion Shares within 5 business days of Conversion Date via DTC or as requested.
• ·Note surrender not required prior to share delivery; full conversion fully satisfies the Note.
• ·Holder responsible for taxes on issuance except certain transfer taxes.

29-04-2026

York Space Systems, Inc. entered into an Agreement and Plan of Merger dated April 29, 2026, to acquire All.Space Holdings, Inc. via a two-step merger with Project Morpheus Merger Sub I, Inc. and Project Morpheus Merger Sub II, LLC, followed by contributions of the surviving entity to Yellowstone Midco Holdings, LLC, Yellowstone InterCo Holdings, LLC, and Yellowstone Borrower, LLC. The transaction was unanimously approved by the Company's Special Committee, Board (excluding Parent affiliates), and requisite shareholders holding a majority of common/preferred stock and 75% of preferred stock. Key terms include a $5,000,000 Adjustment Escrow Amount and 5,882,352 Parent Shares as Aggregate Equity Consideration.

• ·Company formed on November 17, 2025, following redomiciliation from All.Space Networks Limited via Reorganization Agreement dated February 4, 2026.
• ·Mergers intended to qualify as a tax-free reorganization under Section 368(a) of the Code.
• ·Certain securityholders entered Restrictive Covenant Agreements, effective upon Closing.

29-04-2026

Merlin, Inc. (Nasdaq: MRLN) announced an $80 million PIPE investment from an existing institutional shareholder, issuing 8 million shares of common stock and warrants to purchase 4 million shares at $6.67 per share (5-year expiry). The proceeds will bolster cash reserves from approximately $107 million to $183 million, supporting platform development, regulatory approvals, and customer contract expansion. The transaction is expected to close on or about May 1, 2026.

• ·Placement agents: Cantor Fitzgerald & Co. (lead), TD Cowen (co-placement agent).
• ·Legal counsel: Latham & Watkins, LLP (Merlin); Jones Day (placement agents).
• ·Securities issued under Section 4(a)(2) of Securities Act; Merlin to file resale registration statement.
• ·Warrants expiry: 5 years from issue date.

29-04-2026

Laser Photonics Corporation (NASDAQ: LASE) closed the exercise of 5,715,085 warrants originally issued in February 2026 at $0.70 per share, generating approximately $4 million in gross proceeds before fees and expenses. In exchange, the company issued new unregistered Series A-5 warrants for 4,742,860 shares and Series A-6 warrants for 6,687,310 shares, both at $0.975 per share, exercisable post-stockholder approval, which introduces potential future dilution. Net proceeds will fund working capital and general corporate purposes.

• ·Original warrants exercise price: $0.70 per share.
• ·New warrants exercise price: $0.975 per share.
• ·Series A-5 warrants expire five years after the later of stockholder approval or Resale Registration Statement effective date.
• ·Series A-6 warrants expire twenty-four months after the later of stockholder approval or Resale Registration Statement effective date.
• ·H.C. Wainwright & Co. acted as exclusive placement agent.
• ·Filing date: April 29, 2026; original warrants issued February 2026.

29-04-2026

Honda Auto Receivables 2026-2 Owner Trust filed an 8-K on April 29, 2026, under Items 6.01 and 9.01, providing static pool data on prior securitizations of American Honda Finance Corporation from January 1, 2021, to February 28, 2026, as Exhibit 99.1 pursuant to Regulation AB Item 1105. The exhibit includes summary information on original pool characteristics, cumulative net losses, prepayments, delinquencies, and graphical data. The filing explicitly cautions that past static pool performance may not predict future results due to differing receivable characteristics and economic conditions.

• ·Central Index Key Numbers: Issuing Entity 0002123682, Depositor 0000890975, Sponsor 0000864270
• ·Principal executive offices: 1919 Torrance Boulevard, Torrance, California 90501
• ·Telephone: (310) 781-4100